首页> 外国专利> SELECTIVE LIGANDS OF RECEPTORS 5-HT 1D?-5HT 1B? DERIVED FROM INDOLE-PIPERAZINE USEFUL AS MEDICAMENTS

SELECTIVE LIGANDS OF RECEPTORS 5-HT 1D?-5HT 1B? DERIVED FROM INDOLE-PIPERAZINE USEFUL AS MEDICAMENTS

机译:受体5-HT 1D?-5HT 1B的选择性配体吲哚哌嗪类药物

摘要

PCT No. PCT/FR93/01317 Sec. 371 Date Jun. 29, 1995 Sec. 102(e) Date Jun. 29, 1995 PCT Filed Dec. 29, 1993 PCT Pub. No. WO94/15916 PCT Pub. Date Jul. 21, 1994The present invention relates to compounds having the formula: IMAGE wherein R1 is a hydrogen atom, a linear or branched alkyl radical or a phenyl, benzyl, cycloalkyl, polycycloalkyl, dibenzocycloalkyl, dibenzooxepine, dibenzoazepine, dibenzothiepine, benzopyrrolocycloalkyl, benzothienocycloalkyl or naphthyl radical, optionally substituted by one or a number of substituents chosen from halogen atoms and alkyl, aryl acyl, alkoxy and alkyl thio radicals. Z is C=O, SO2 or (CH2)n in which n is between 1 and 5. R2 is a hydrogen atom, a linear or branched alkyl radical or a phenyl, benzyl, cycloalkyl, pyrrole, furan, pyridinyl or thiophenyl radical, optionally substituted by one or a number of substituents chosen from halogen atoms and alkyl, aryl, acyl, alkoxy and alkylthio radicals. R'2 is a hydrogen atom, a linear or branched alkyl radical or a phenyl radical. R3 is a hydrogen atom, a linear or branched alkyl radical or a benzyl or phenethyl radical. R4 is a hydrogen, chlorine, fluorine or bromine atom or a linear or branched alkyl radical. R5 is a hydrogen atom, a linear or branched alkyl radical or a benzyl or phenethyl radical. R6 is a hydrogen atom, a linear or branched alkyl radical, an acyl (COR7), acyloxy (CO2R7) or acylamino (CONHR7) radical in which R7 represents a linear or branched alkyl radical, or a variously substituted phenyl radical.
机译:PCT号PCT / FR93 / 01317秒371日期1995年6月29日秒102(e)1995年6月29日PCT申请日期1993年12月29日提交PCT Pub。 WO94 / 15916 PCT公开号1994年7月21日,日期,本发明涉及具有下式的化合物:其中R 1为氢原子,直链或支链烷基或苯基,苄基,环烷基,聚环烷基,二苯并环烷基,二苯并氧杂环庚烷,二苯并氮杂卓,二苯并硫庚因,苯并吡咯并环烷基,苯并噻吩并环烷基或萘基,任选地被一个或多个选自卤素原子和烷基,芳基酰基,烷氧基和烷基硫基的取代基取代。 Z为C = O,SO2或(CH2)n,其中n为1至5。R2为氢原子,直链或支链烷基或苯基,苄基,环烷基,吡咯,呋喃,吡啶基或硫代苯基,任选地被一个或多个选自卤素原子和烷基,芳基,酰基,烷氧基和烷硫基的取代基取代。 R’2是氢原子,直链或支链的烷基或苯基。 R 3是氢原子,直链或支链的烷基或苄基或苯乙基。 R 4是氢,氯,氟或溴原子或直链或支链烷基。 R 5是氢原子,直链或支链烷基或苄基或苯乙基。 R6是氢原子,直链或支链的烷基,酰基(COR7),酰氧基(CO2R7)或酰氨基(CONHR7)的基团,其中R7代表直链或支链的烷基或各种取代的苯基。

著录项

  • 公开/公告号EP0677042A1

    专利类型

  • 公开/公告日1995-10-18

    原文格式PDF

  • 申请/专利权人 PIERRE FABRE MEDICAMENT;

    申请/专利号EP19940903929

  • 发明设计人 HALAZY SERGE;PEREZ MICHEL;BRILEY MICHAEL;

    申请日1993-12-29

  • 分类号C07D209/16;A61K31/40;C07D409/12;

  • 国家 EP

  • 入库时间 2022-08-22 04:12:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号